Benzinga - Wed, 07 Apr 2021 08:12:41 -0400
Benzinga - Fri, 26 Mar 2021 04:59:29 -0400
Benzinga - Thu, 25 Mar 2021 10:17:35 -0400
Benzinga - Tue, 16 Mar 2021 16:24:42 -0400
Benzinga - Tue, 16 Mar 2021 04:46:43 -0400
load more
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-11
REV
Q4 2020Est.ActualSurprise
EPS-0.090-0.110 -0.0200
REV2.840M3.024M184.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CRISCuris1.45%962.8M

Curis Company Questions & Answers

Q

How do I buy Curis (CRIS) stock?

A

You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Curis's (CRIS) main competitors?

A

There are no as such competitors for Curis.

Q

What is the target price for Curis?

A

The latest price target for Curis (NASDAQ: CRIS) was reported by B. Riley FBR on 2021-03-25. The analyst firm set a price target for 19.00 expecting CRIS to rise to within 12 months (a possible 80.61% upside). 5 analyst firms have reported ratings in the last year.

Q

How much is Curis (CRIS) stock ?

A

The stock price for Curis (NASDAQ: CRIS) is $10.52 last updated Thu Apr 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Curis (CRIS) dividend?

A

There are no upcoming dividends for Curis.

Q

When is Curis (NASDAQ:CRIS) reporting earnings?

A
Curis’s Q1 earnings are confirmed from now on May 11, 2021.
Q

When is the upcoming split for CRIS?

A

There is no upcoming split for Curis.